Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split

view original post

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new …